| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.099 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |